Back to top

Image: Bigstock

Intellia (NTLA) Catches Eye: Stock Jumps 7.8%

Read MoreHide Full Article

Intellia Therapeutics, Inc. (NTLA - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up 68.9% in the past one-month time frame.
 
The company has seen five positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Intellia. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Intellia currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.  

Investors interested in the Medical - Biomedical and Genetics industry may consider ASLAN Pharmaceuticals Limited (ASLN - Free Report) , which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Intellia Therapeutics, Inc. (NTLA) - free report >>

ASLAN Pharmaceuticals Ltd. (ASLN) - free report >>